Companies: 10,795·Total market cap: $144.5T
ClearPoint Neuro, Inc.

ClearPoint Neuro, Inc.

CLPTNASDAQHealthcare● Active
$12.89
$-1.43(-9.99%)
Market Cap$386565467
P/E Ratio
52W High$30.1
52W Low$8.27

ClearPoint Neuro, Inc.(CLPT)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · CLPT · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$36.97M$31.39M$23.95M$20.55M$16.30M
Cost of Revenue$14.28M$12.27M$10.34M$7.02M$5.18M
Gross Profit$22.69M$19.12M$13.61M$13.53M$11.12M
Gross Margin %(computed)61.38%60.92%56.83%65.84%68.24%
Operating Expenses
R&D Expenses$13.90M$12.39M$11.71M$10.89M$9.28M
G&A Expenses$16.50M$12.00M$11.76M$9.61M$8.00M
Total Operating Expenses$46.86M$38.87M$36.06M$29.86M$24.50M
Operating Income($24.16M)($19.75M)($22.45M)($16.33M)($13.37M)
Operating Margin %(computed)-65.36%-62.91%-93.70%-79.47%-82.05%
Interest Income$1.21M$0.87M$0.39M$0.00M$0.00M
Interest Expense$2.39M$0.00M$0.00M$0.08M$0.97M
Income Before Tax($25.48M)($18.91M)($22.09M)($16.43M)($14.41M)
Income Tax Expense$0.06M$0.00M$0.00M$0.00M$0.00M
Net Income($25.54M)($18.91M)($22.09M)($16.43M)($14.41M)
Net Margin %(computed)-69.08%-60.25%-92.21%-79.97%-88.41%
Per Share & EBITDA
EPS (Basic)$-0.90$-0.70$-0.90$-0.68$-0.69
Wtd Avg Shares28.32M27.03M24.61M24.18M20.73M
EBITDA($21.93M)($17.84M)($20.99M)($15.58M)($12.74M)
EBITDA Margin %(computed)-59.31%-56.84%-87.62%-75.80%-78.19%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · M

深入了解ClearPoint Neuro, Inc.

关于ClearPoint Neuro, Inc.(CLPT)损益表

ClearPoint Neuro, Inc.(CLPT)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,CLPT实现营收$0.04B,毛利润$0.02B(毛利率61.38%),净利润($0.03B)(净利率-69.08%)。

常见问题

CLPT · 4 问

ClearPoint Neuro, Inc.(CLPT)2025财年营收为$0.04B,同比up17.8%。

CLPT revenueCLPT salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08